Charlotte's Web Holdings, Inc. is a manufacturer and distributor of hemp-derived cannabidiol (CBD) and botanical-based wellness products. The company operates in a single segment focused on hemp-derived CBD wellness products, offering hemp extract oil tinctures, gummies, capsules, topical creams, lotions, pet products, and functional mushroom gummies. Its brand portfolio includes Charlotte’s Web, CBD Medic, and CBD Clinic. The company sources hemp from contract farms in the United States and Canada, with Canadian-grown hemp reserved exclusively for the Canadian market. It maintains a cGMP-compliant production facility in Louisville, Colorado, where it conducts manufacturing, quality control, and research and development activities. In February 2020, the company established CW Labs, an internal division for research and clinical trials involving hemp-derived compounds. In April 2023, Charlotte's Web co-founded DeFloria, Inc. with AJNA BioSciences and a subsidiary of British American Tobacco to pursue FDA approval for a botanical drug targeting a neurological condition. The company sells its products through select distributors, healthcare practitioners, its own website, and third-party e-commerce platforms. It previously held an exclusive strategic partnership with Major League Baseball, which was terminated in May 2025. The company does not produce or sell medicinal or recreational marijuana or products derived from high-THC cannabis plants.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Household & Personal Products Homepage investors.charlottesweb.com
Sector Consumer Defensive IR page investors.charlottesweb.com/overview/default.aspx
Tags
cbd wellness, hemp extracts, functional mushrooms, botanical supplements, pet wellness, topical skincare, clinical research, contract farming, vertical integration, Charlotte’s Web, CBD Medic, CBD Clinic, CW Labs, DeFloria Inc., AJNA BioSciences, British American Tobacco, Stanley Brothers USA Holdings Inc., Route CBD, Edibles.com, Focus Support, Stress Support, Energy Support
Press page —

Metrics

Valuation  
Market cap C$ 74.035M
Market cap (USD) $ 51.754M
P/E -1.52
PEG —
P/BV 1.39
P/S 1.66
P/OCF -9.09
P/FCF -9.14
Dividend yield —
Turnover / mcap —
Returns  
ROE 1,458.6%
ROI -1,408.2%
ROIC -719.7%
Profit margin -59.6%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 4
Quality score -44.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024
Revenue 49.897M 49.667M
Net profit -29.741M -29.846M

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Operating loss narrows to its lowest level since 2019 despite lower revenue, as costs and margins improve

Louisville, Colo., November 12, 2026 - (TSX: CWEB, OTCQX: CWBHF), Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended September 30, 2026. All amounts are expressed in U.S. dollars unless otherwise indicated.

“Third-quarter revenue primarily reflected the restrictions on the sale of full-spectrum hemp products in California that took effect in July. We have since reintroduced broad-spectrum products in California and sales have steadily begun to recover there. Nationally, we have sharply reduced deep discounting so that our pricing reflects the premium quality and reliable efficacy customers expect from Charlotte’s Web. That lowered revenue in the near term, but it also improved margins and helped deliver our smallest operating loss since 2019,” said Bill Morachnick, Chief Executive Officer of Charlotte’s Web.

October 28, 2026

Louisville, Colorado--(Newsfile Corp. - October 28, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and market leader in cannabidiol (CBD) hemp extract wellness products , will report its 2026 third quarter financial results before market open on November 12, 2026, and will file its Quarterly Report on Form 10-Q the same day.

Rather than hold a shareholder call on November 12, the Company intends to host a single corporate update call and webcast in December, after December 11, 2026, when the revised federal definition of hemp is scheduled to take full effect under current law. The call will review federal hemp policy developments and their implications for the industry and the Company, as well as other corporate developments. Dial-in and webcast details will be provided in a separate notice.

"It is important to have more clarity on federal policy before we hold our shareholder call," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "Federal rules that will shape our category are scheduled to take effect by December 11, and once we have these in hand we can provide an outlook based on actual plans as opposed to speculation. We appreciate our shareholders' patience and look forward to sharing an update in December."

Subscribe to Charlotte's Web investor news.

About Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD (cannabidiol) extracts as well as broad-spectrum CBD and other naturally occurring cannabinoid isolates, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte's Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company's website at www.charlottesweb.com .

Shares of Charlotte's Web trade on the TSX under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF". Subscribe to Charlotte's Web investor news.

September 2, 2026

House Passage of Continuing Resolution Provides Congress Additional Runway to Establish Baseline Industry Regulations

Louisville, Colorado--(Newsfile Corp. - September 2, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp extract wellness products, today welcomed the U.S. House of Representatives' passage of the continuing resolution (CR), which was approved by a vote of 370-48, following the Senate's earlier passage of the measure. The legislation will now be sent to the President for signature and enactment into law.

The passage of the CR helps ensure continuity of government operations while providing additional time until December 11, 2026, for Congress to complete work on longer-term policy priorities. This measure delays the November 12th ban on naturally derived hemp products while maintaining the prohibition on synthetic cannabinoids.

"Charlotte's Web appreciates the House's action to advance this legislation and give Congress time to develop thoughtful regulation that separates naturally derived, therapeutic products from intoxicating synthetics and high-THC products," said Bill Morachnick, CEO of Charlotte's Web. "Regulatory certainty is critical for businesses, consumers, farmers, and stakeholders across the hemp industry. We are encouraged to see lawmakers come together to advance an opportunity for the broader policy discussions to continue."

As the nation's leading hemp CBD wellness company, Charlotte's Web remains committed to advocating for science-based regulations and a clear federal framework that protects consumers, supports responsible businesses, and enables continued innovation across the hemp-derived product marketplace.

Mr. Morachnick added, "The future of therapeutic hemp should not be defined by the highest-risk products in the category. It should be defined by consumer safety, product integrity, and science. We believe lawmakers can deliver a framework that protects Americans while preserving access to the wellness products that have helped so many people improve their quality of life."

**About Charlotte's Web Holdings, Inc.
**Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD and cannabinoid isolates. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf. Shares of Charlotte's Web trade on the TSX under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF".

Prompts

Charlotte's Web Holdings, Inc. (ticker CWEB), listed in United States.

ETFs Holding Charlotte's Web Holdings, Inc.

ETF Weight in ETF Shares Market value As of
CNBS 0.04% 112,025 $ 34.755K Jun 30, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
CWEB Common share — CA tsx — —
CWBHF canonical Common share — US otc 0.27 USD 2026-09-30